UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial

Critical care (London, England), 2016-10, Vol.20 (1), p.329-329, Article 329

2016

Volltextzugriff (PDF)

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19

Intensive care medicine, 2020-11, Vol.46 (11), p.2067-2070

2020

Volltextzugriff (PDF)

Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019

Critical care explorations, 2020-04, Vol.2 (4), p.e0111-e0111

2020

Volltextzugriff (PDF)

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine

Critical care medicine, 2008-06, Vol.36 (6), p.1937-1949

2008

Volltextzugriff (PDF)

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review

JAMA : the journal of the American Medical Association, 2009-06, Vol.301 (22), p.2362

2009

Volltextzugriff (PDF)

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply

Intensive care medicine, 2021-03, Vol.47 (3), p.357-358

2021

Volltextzugriff (PDF)

Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia

Open forum infectious diseases, 2020-10, Vol.7 (10), p.ofaa421

2020

Volltextzugriff (PDF)

Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature

Intensive care medicine, 2008-01, Vol.34 (1), p.61-69

2008

Volltextzugriff (PDF)

Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome

Critical care medicine, 2012-02, Vol.40 (2), p.495-501

2012

Volltextzugriff (PDF)

Prolonged Methylprednisolone Treatment Suppresses Systemic Inflammation in Patients with Unresolving Acute Respiratory Distress Syndrome . Evidence for Inadequate Endogenous Glucocorticoid Secretion and Inflammation-induced Immune Cell Resistance to Glucocorticoids

American journal of respiratory and critical care medicine, 2002-04, Vol.165 (7), p.983-991

2002

Volltextzugriff (PDF)

Methylprednisolone: Likely an Effective Treatment in Acute Respiratory Distress Syndrome

Critical care medicine, 2019-04, Vol.47 (4), p.e374-e375

2019

Volltextzugriff (PDF)

Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome

Pediatric critical care medicine, 2015-03, Vol.16 (3), p.e74-e81

2015

Volltextzugriff (PDF)

Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement

Intensive care medicine, 2011-09, Vol.37 (9), p.1553-1554

2011

Volltextzugriff (PDF)

Acute respiratory failure in patients with severe community-acquired pneumonia : A prospective randomized evaluation of noninvasive ventilation

American journal of respiratory and critical care medicine, 1999-11, Vol.160 (5), p.1585-1591

1999

Volltextzugriff (PDF)

Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature

Intensive Care Medicine, 2016-05, Vol.42 (5), p.829-840

2016

Volltextzugriff (PDF)

Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy

Clinical immunology (Orlando, Fla.), 2020-10, Vol.219, p.108550-108550, Article 108550

2020

Volltextzugriff (PDF)

Systemic Inflammation-Associated Glucocorticoid Resistance and Outcome of ARDS

Annals of the New York Academy of Sciences, 2004-06, Vol.1024 (1), p.24-53

2004

Volltextzugriff (PDF)

Caution When Comparing the Impact of Corticosteroids in COVID-19

Chest, 2021-08, Vol.160 (2), p.e243-e244

2021

Volltextzugriff (PDF)

MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale

Expert review of anti-infective therapy, 2021-02, Vol.19 (2), p.129-135

2021

Volltextzugriff (PDF)

Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial

Chest, 2007-04, Vol.131 (4), p.954-963

2007

Volltextzugriff (PDF)

Dysregulated Systemic Inflammation Favors Bacterial Growth and Development of Nosocomial Infections

American journal of respiratory and critical care medicine, 2018-04, Vol.197 (8), p.1092-1092

2018

Volltextzugriff (PDF)

Clinical and Scientific Rationale for the "MATH+" Hospital Treatment Protocol for COVID-19

Journal of intensive care medicine, 2021-02, Vol.36 (2), p.135-156

2021

Volltextzugriff (PDF)

An Exploratory Reanalysis of the Randomized Trial on Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome

Critical care medicine, 2018-06, Vol.46 (6), p.884-891

2018

Volltextzugriff (PDF)

Glucocorticoid Treatment in Acute Lung Injury and Acute Respiratory Distress Syndrome

Critical care clinics, 2011-07, Vol.27 (3), p.589-607

2011

Volltextzugriff (PDF)

Noninvasive Mechanical Ventilation in Acute Respiratory Failure: Happy 30-Year Anniversary

Chest, 2020-02, Vol.157 (2), p.255-257

2020

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(146)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Englisch
(152)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(106)
Science & Technology
(106)
Humans
(96)
General & Internal Medicine
(76)
Critical Care Medicine
(65)
Respiratory System
(49)
Biological And Medical Sciences
(44)
Medical Sciences
(43)
Male
(40)
Female
(38)
Middle Aged
(36)
Adult
(25)
Respiratory Distress Syndrome, Adult - Drug Therapy
(24)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(23)
Intensive Care Medicine
(23)
Glucocorticoids - Therapeutic Use
(21)
Acute Respiratory Distress Syndrome
(20)
Aged
(20)
Treatment Outcome
(20)
Mortality
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19

Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19. Author's reply

Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia

Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature

Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome

Prolonged Methylprednisolone Treatment Suppresses Systemic Inflammation in Patients with Unresolving Acute Respiratory Distress Syndrome . Evidence for Inadequate Endogenous Glucocorticoid Secretion and Inflammation-induced Immune Cell Resistance to Glucocorticoids

Methylprednisolone: Likely an Effective Treatment in Acute Respiratory Distress Syndrome

Double-blind, placebo-controlled pilot randomized trial of methylprednisolone infusion in pediatric acute respiratory distress syndrome

Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement

Acute respiratory failure in patients with severe community-acquired pneumonia : A prospective randomized evaluation of noninvasive ventilation

Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients’ data from four randomized trials and trial-level meta-analysis of the updated literature

Critical COVID-19 disease, homeostasis, and the “surprise” of effective glucocorticoid therapy

Systemic Inflammation-Associated Glucocorticoid Resistance and Outcome of ARDS

Caution When Comparing the Impact of Corticosteroids in COVID-19

MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale

Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial

Dysregulated Systemic Inflammation Favors Bacterial Growth and Development of Nosocomial Infections

Clinical and Scientific Rationale for the "MATH+" Hospital Treatment Protocol for COVID-19

An Exploratory Reanalysis of the Randomized Trial on Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome

Glucocorticoid Treatment in Acute Lung Injury and Acute Respiratory Distress Syndrome

Noninvasive Mechanical Ventilation in Acute Respiratory Failure: Happy 30-Year Anniversary

Suchergebnisse filtern